Gastric restitution is inhibited by dexamethasone, which is reversed by hepatocyte growth factor and rebamipide

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 18, Issue 1, 2003, Pages 126-132

  Takahashi, M ^a   Takada, H ^a   Takagi, K ^a   Kataoka, S ^a   Soma, R ^a   Kuwayama, H ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; DEXAMETHASONE; MESSENGER RNA; PROSTAGLANDIN; PROSTAGLANDIN E2; REBAMIPIDE; SCATTER FACTOR; ALANINE; ANTIINFLAMMATORY AGENT; ANTIULCER AGENT; DRUG DERIVATIVE; ISOENZYME; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN; QUINOLONE DERIVATIVE;

COCULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH EPITHELIUM; STOMACH ULCER; ARTICLE; CELL CULTURE; DRUG ANTAGONISM; METABOLISM; STOMACH MUCOSA;

ALANINE; ANTI-INFLAMMATORY AGENTS; ANTI-ULCER AGENTS; CELLS, CULTURED; CYCLOOXYGENASE 2; DEXAMETHASONE; DINOPROSTONE; FIBROBLASTS; GASTRIC MUCOSA; HEPATOCYTE GROWTH FACTOR; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; QUINOLONES; RNA, MESSENGER;

EID: 0242684448     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.18.s1.19.x     Document Type: Conference Paper

References (22)

1. Garb AE, Soule EH, Bartholomew LG, Cain JC. Steroid-induced gastric ulcer. A clinicopathologic study. Arch Intern Med 1965; 116(6): 899-906.
2. Messer J, Reitman D, Sacks HS, Smith H Jr, Chalmers TC. Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med 1983; 309(1): 21-4.
3. Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991; 114(9): 735-40.
4. Takahashi M, Ota S, Terano A, et al. Hepatocyte growth factor induces mitogenic reaction to the rabbit gastric epithelial cells in primary culture. Biochem Biophys Res Commun 1993; 191: 528-34.
5. Watanabe S, Hirose M, Wang X, et al. Hepatocyte growth factor accelerates the wound repair of cultured gastric mucosal cells. Biochem Biophys Res Commun 1994; 199: 1453-60.
6. Takahashi M, Ota S, Shimada T, et al. Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture. J Clin Invest 1995; 95: 1994-2003.
7. Takahashi M, Ota S, Ogura K, Nakamura T, Omata M. Hepatocyte growth factor stimulates wound repair of the rabbit esophageal epithelial cells in primary culture. Biophys Biochem Res Commun 1995; 216: 298-305.
8. Takahashi M, Ota S, Hata Y, et al. Hepatocyte growth factor as a key to modulate anti-ulcer actions of prostaglandins in stomach. J Clin Invest 1996; 98: 2604-11.
9. Mizuno H, Sakamoto C, Matsuda K, et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 1997; 112: 387-97.
10. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids, inhibition of NF-κB activity through induction of IκB synthesis. Science 1995; 270(5234): 286-90. (See Comments.)
11. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of IκB alpha in mediation of immunosuppression by glucocorticoids Science 1995; 270(5234): 283-6. (See Comments.)
12. Marx J. How the glucocorticoids suppress immunity. Science 1995; 270(5234): 232-3. (See Comments.)
13. Yao XL, Cowan MJ, Gladwin MT, Lawrence MM, Angus CW, Shelhamer JH. Dexamethasone alters arachidonate release from human epithelial cells by induction of p11 protein synthesis and inhibition of phospholipase A2 activity. J Biol Chem 1999; 274(24): 17202-8.
14. Inoue H, Umesono K, Nishimori T, Hirata Y, Tanabe T. Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells. Biochem Biophys Res Commun 1999; 254(2): 292-8.
15. Bauer MK, Lieb K. Schulze-Osthoff K, et al. Expression and regulation of cyclooxygenase-2 in rat microglia. Eur J Biochem 1997; 243(3): 726-31.
16. Fiebich BL, Mueksch B, Boehringer M, Hull M. Interleukin-1beta induces cyclooxygenase-2 and prostaglandin E(2) synthesis in human neuroblastoma cells: involvement of p38 mitogen- activated protein kinase and nuclear factor-kappaB. J Neurochem 2000; 75(5): 2020-8.
17. Migita K, Tanaka H, Okamoto K, et al. FK506 augments glucocorticoid-mediated cyclooxygenase-2 down-regulation in human rheumatoid synovial fibroblasts. Laboratory Invest 2000; 80(2): 135-41.
18. Gupta C, Katsumata M, Goldman AS, Herold R, Piddington R. Glucocorticoid-induced phospholipase A2-inhibitory proteins mediate glucocorticoid teratogenicity in vitro. Proc Natl Acad Sci USA 1984; 81(4): 1140-3.
19. Takahashi M, Katayama Y, Takada H, Kuwayama H, Terano A. The effect of NSAIDs and a COX-2 specific inhibitor on Helicobacter pylori-induced PGE2 and HGF in human gastric fibroblasts. Aliment Pharmacol Ther 2000; 14(Suppl. 1): 44-9.
20. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 1991; 88(16): 7276-80.
21. Shimokawa T, Kato M, Ezaki O, Hashimoto S. Transcriptional regulation of muscle-specific genes during myoblast differentiation. Biochem Biophys Res Commun 1998; 246(1): 287-92.
22. Lakowicz JR. Energy Transfer. In: Principles of Fluorescent Spectroscopy. New York: Plenum, 1983: 303-39.